Add a listing
    Add a listing

    Treefrog Therapeutics

      Human induced pluripotent stem cell regenerative medicine therapies at scale. Encapsulation technology.

    General
    • Headquarters

      Pessac, Gironde, France

    • Founders & Team

      Erwan Bezard, Jean-Luc Treillou, Kevin Alessandri, Laurent Cognet, Maxime Feyeux, Pierre Nassoy

    • Year Founded

      2018

    • Number of employees

      50

    • Company type

      Private company

    • Total funding ($M)

      11.3

    • Investors

      Aquiti Gestion, Galia Gestion, Irdi Soridec, SATT Aquitaine, XAnge (Siparex Group)

    Technical Details
    • Aging Target

      Cell Loss

    • Disease indication

      Parkinson's disease

    • Product modality

      stem cells, cell therapy

    About

    TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies by overcoming current critical manufacturing issues.

    TreeFrog Therapeutics has developed C-Stem® : a proprietary technology platform that provides an end to end 3D scalable solution that will dramatically reduce treatment costs.

    Through strategic partnership and co-developments, TreeFrog Therapeutics will help cell therapy players to secure cell production and quality, fasten clinical development and facilitate market access.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In